loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Calcipotriene Hydrate

    Client Email Product
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Calcipotriene Hydrate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,074,476Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of June 7, 2023
    Enforcement Report - Week of June 7, 2023

    07 Jun 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf

    FDA
    07 Jun 2023
    Share Share
    Glenmark gets USFDA nod for generic drug with 180-day exclusivity
    Glenmark gets USFDA nod for generic drug with 180-day exclusivity

    23 Mar 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-gets-usfda-nod-for-generic-drug-with-180-day-exclusivity/articleshow/98934035.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    23 Mar 2023
    Share Share
    EPI Health, a Novan Company, and MC2 Therapeutics Present WYNZORA®
    EPI Health, a Novan Company, and MC2 Therapeutics Present WYNZORA®

    15 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/15/2516825/0/en/EPI-Health-a-Novan-Company-and-MC2-Therapeutics-Present-WYNZORA-calcipotriene-and-betamethasone-dipropionate-Cream-0-005-0-064-Subgroup-Data-Analysis-at-Skin-of-Color-Update-2022-C.html

    GLOBENEWSWIRE
    15 Sep 2022
    Share Share
    Enforcement Report - Week of July 6, 2022
    Enforcement Report - Week of July 6, 2022

    06 Jul 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-6-2022-1657105109.pdf

    FDA
    06 Jul 2022
    Share Share
    Glenmark receives ANDA approval for topical treatment of plaque psoriasis
    Glenmark receives ANDA approval for topical treatment of plaque psoriasis

    09 May 2022

    // ET HEALTH

    https://health.economictimes.indiatimes.com/news/pharma/glenmark-receives-anda-approval-for-topical-treatment-of-plaque-psoriasis-in-adults/91434978

    ET HEALTH
    09 May 2022
    Share Share
    EPI Health and MC2 Therapeutics Announce Wynzora(R) Cream (calcipotriene)
    EPI Health and MC2 Therapeutics Announce Wynzora(R) Cream (calcipotriene)

    09 Nov 2021

    // YAHOO

    https://finance.yahoo.com/news/epi-health-mc2-therapeutics-announce-130000824.html

    YAHOO
    09 Nov 2021
    Share Share